Failing heart of patients with type 2 diabetes mellitus can adapt to extreme short-term increases in circulating lipids and does not display features of acute myocardial lipotoxicity

Circulation: Heart Failure

Volumn 6, Issue 4, 2013, Pages 845-852

  Nielsen, Roni ^a   Nørrelund, Helene ^b   Kampmann, Ulla ^a   Kim, Won Yong ^a   Ringgaard, Steffen ^a   Schär, Michael ^c   Møller, Niels ^a   Bøtker, Hans Erik ^a   Wiggers, Henrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

^c PHILIPS HEALTHCARE   (United States)

Author keywords

Echocardiography; Heart failure; Magnetic resonance spectroscopy; Ventricular function, left

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; FATTY ACID; HEPARIN; INTRALIPID; METFORMIN; SONOVUE; SULFONYLUREA; TRIACYLGLYCEROL;

AGED; ARTICLE; BICYCLE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; ECHOCARDIOGRAPHY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEPARIN INFUSION; HUMAN; HYPERINSULINEMICEUGLYCEMIC CLAMPING; IMAGING SOFTWARE; INFUSION; INTRALIPID INFUSION; LIPOTOXICITY; MALE; MYOCARDIAL LIPID CONTENT; MYOCARDIAL LIPOTOXICITY; NEW YORK HEART ASSOCIATION CLASS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND SCANNER; ULTRASOUND TRANSDUCER; ADAPTATION; BLOOD; CONTROLLED CLINICAL TRIAL; DIABETIC ANGIOPATHY; HEART VENTRICLE FUNCTION; LEFT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY;

ECHOCARDIOGRAPHY; HEART FAILURE; LEFT; MAGNETIC RESONANCE SPECTROSCOPY; VENTRICULAR FUNCTION;

ADAPTATION, PHYSIOLOGICAL; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FATTY ACIDS, NONESTERIFIED; HEART FAILURE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN CONSUMPTION; TRIGLYCERIDES;

EID: 84884718202     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.113.000187     Document Type: Article

References (36)

1. Taegtmeyer H, Golfman L, Sharma S, Razeghi P, van Arsdall M. Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann N Y Acad Sci. 2004;1015:202-213.
2. Szczepaniak LS, Victor RG, Orci L, Unger RH. Forgotten but Not Gone. Circulation. Research. 2007;101:759-767.
3. McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine BD, Raskin P, Victor RG, Szczepaniak LS. Cardiac Steatosis in Diabetes Mellitus. Circulation. 2007;116:1170-1175.
4. Hammer S, van der Meer RW, Lamb HJ, de Boer HH, Bax JJ, de Roos A, Romijn JA, Smit JW. Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab. 2008;295:E714-E718.
5. Nørrelund H, Wiggers H, Halbirk M, Frystyk J, Flyvbjerg A, Bøtker HE, Schmitz O, Jørgensen JO, Christiansen JS, Møller N. Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med. 2006;260:11-21.
6. Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol. 2004;44:1030-1035.
7. Wiggers H, Nørrelund H, Nielsen SS, Andersen NH, Nielsen-Kudsk JE, Christiansen JS, Nielsen TT, Møller N, Bøtker HE. Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium. Am J Physiol Heart Circ Physiol. 2005;289:H938-H946.
8. Nikitin NP, Loh PH, Silva Rd, Ghosh J, Khaleva OY, Goode K, Rigby AS, Alamgir F, Clark AL, Cleland JG. Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction. Heart. 2006;92:775-779.
9. Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS. Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab. 2005;289:E935-E939.
10. Nikitin NP, Witte KK, Thackray SD, de Silva R, Clark AL, Cleland JG. Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative twodimensional color Doppler tissue imaging. J Am Soc Echocardiogr. 2003;16:906-921.
11. Tsujita-Kuroda Y, Zhang G, Sumita Y, Hirooka K, Hanatani A, Nakatani S, Yasumura Y, Miyatake K, Yamagishi M. Validity and reproducibility of echocardiographic measurement of left ventricular ejection fraction by acoustic quantification with tissue harmonic imaging technique. J Am Soc Echocardiogr. 2000;13:300-305.
12. van der Meer RW, Doornbos J, Kozerke S, Schär M, Bax JJ, Hammer S, Smit JW, Romijn JA, Diamant M, Rijzewijk LJ, de Roos A, Lamb HJ. Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology. 2007;245:251-257.
13. Van Beaumont W, Greenleaf JE, Juhos L. Disproportional changes in hematocrit, plasma volume, and proteins during exercise and bed rest. J Appl Physiol. 1972;33:55-61.
14. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207-258.
15. Halbirk M, Nørrelund H, Møller N, Schmitz O, Gøtzsche L, Nielsen R, Nielsen-Kudsk JE, Nielsen SS, Nielsen TT, Eiskjær H, Bøtker HE, Wiggers H. Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function. Am J Physiol Heart Circ Physiol. 2010;299:H1220-H1225.
16. Tuunanen H, Engblom E, Naum A, Någren K, Hesse B, Airaksinen KE, Nuutila P, Iozzo P, Ukkonen H, Opie LH, Knuuti J. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation. 2006;114:2130-2137.
17. Lehto HR, Pärkkä J, Borra R, Tuunanen H, Lepomaki V, Parkkola R, Knuuti J, Nuutila P, Iozzo P. Effects of acute and one-week fatty acid lowering on cardiac function and insulin sensitivity in relation with myocardial and muscle fat and adiponectin levels. J Clin Endocrinol Metab. 2012;97:3277-3284.
18. van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ. Metabolic remodelling of the failing heart: beneficial or detrimental? Cardiovasc Res. 2009;81:420-428.
19. Nikitin NP, Witte KK, Thackray SD, de Silva R, Clark AL, Cleland JG. Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color Doppler tissue imaging. J Am Soc Echocardiogr. 2003;16:906-921.
20. Mogelvang R, Sogaard P, Pedersen SA, Olsen NT, Schnohr P, Jensen JS. Tissue Doppler echocardiography in persons with hypertension, diabetes, or ischaemic heart disease: the Copenhagen City Heart Study. Eur Heart J. 2009;30:731-739.
21. Oki T, Fukuda K, Tabata T, Mishiro Y, Yamada H, Abe M, Onose Y, Wakatsuki T, Iuchi A, Ito S. Effect of an acute increase in afterload on left ventricular regional wall motion velocity in healthy subjects. J Am Soc Echocardiogr. 1999;12:476-483.
22. Amà R, Segers P, Roosens C, Claessens T, Verdonck P, Poelaert J. The effects of load on systolic mitral annular velocity by tissue Doppler imaging. Anesth Analg. 2004;99:332-338, table of contents.
23. Quintard H, Muller L, Philip I, Lena P, Ichai C. Influence of acute preload changes on mitral annulus velocity measured by tissue Doppler echocardiography in critically ill patients. J Clin Ultrasound. 2012;40:419-423.
24. Winhofer Y, Krssák M, Jankovic D, Anderwald CH, Reiter G, Hofer A, Trattnig S, Luger A, Krebs M. Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjects. Diabetes. 2012;61:1210-1216.
25. Giustina A, Volterrani M, Manelli F, Desenzani P, Poiesi C, Lorusso R, Giordano A. Endocrine predictors of acute hemodynamic effects of growth hormone in congestive heart failure. Am Heart J. 1999;137:1035-1043.
26. Thuesen L, Christiansen JS, Sørensen KE, Orskov H, Henningsen P. Low-dose intravenous glucagon has no effect on myocardial contractility in normal man. An echocardiographic study. Scand J Clin Lab Invest. 1988;48:71-75.
27. Johansson BL, Sundell J, Ekberg K, Jonsson C, Seppänen M, Raitakari O, Luotolahti M, Nuutila P, Wahren J, Knuuti J. C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients. Am J Physiol Endocrinol Metab. 2004;286:E14-E19.
28. Iozzo P. Seeing is believing: dietary fatty acids hurry up from the stomach to the heart of patients with impaired glucose tolerance. Diabetes. 2012;61:2659-2660.
29. Nielsen R, Nørrelund H, Kampmann U, Bøtker HE, Møller N, Wiggers H. Effect of acute hyperglycemia on left ventricular contractile function in diabetic patients with and without heart failure: two randomized crossover studies. PLoS One. 2013;8:e53247.
30. Ng AC, Delgado V, Bertini M, van der Meer RW, Rijzewijk LJ, Hooi Ewe S, Siebelink HM, Smit JW, Diamant M, Romijn JA, de Roos A, Leung DY, Lamb HJ, Bax JJ. Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation. 2010;122:2538-2544.
31. Marfella R, Di Filippo C, Portoghese M, Barbieri M, Ferraraccio F, Siniscalchi M, Cacciapuoti F, Rossi F, D'Amico M, Paolisso G. Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. J Lipid Res. 2009;50:2314-2323.
32. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, Taegtmeyer H. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 2004;18:1692-1700.
33. Brindley DN, Kok BP, Kienesberger PC, Lehner R, Dyck JR. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am J Physiol Endocrinol Metab. 2010;298:E897-E908.
34. van de Weijer T, Schrauwen-Hinderling VB, Schrauwen P. Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc Res.. 2011;92:10-18.
35. Labbé SM, Grenier-Larouche T, Noll C, Phoenix S, Guérin B, Turcotte EE, Carpentier AC. Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans. Diabetes. 2012;61:2701-2710.
36. Knuuti MJ, Mäki M, Yki-Järvinen H, Voipio-Pulkki LM, Härkönen R, Haaparanta M, Nuutila P. The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol. 1995;27:1359-1367.